Santen Pharmaceutical Co., Ltd. is a publicly traded company trading on OTC, led by CEO Takeshi Ito.
Upcoming earnings announcement for Santen Pharmaceutical Co., Ltd.
Past 11 earnings reports for Santen Pharmaceutical Co., Ltd.
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Aug 7, 2025 | Q1 2025 | $0.12 | — | $475.5M | — | — |
| Feb 6, 2025 | Q3 2024 | $0.20 | — | $501.4M | — | — |
| Nov 7, 2024 | Q2 2024 | $0.24 | — | $493.2M | — | — |
| Aug 6, 2024 | Q1 2024 | $0.22 | — | $479.8M | — | — |
| May 9, 2024 | Q4 2023 | $0.16 | — | $533.3M | — | — |
| Feb 13, 2024 | Q3 2023 | $0.25 | — | $521.4M | — | — |
| Nov 7, 2023 | Q2 2023 | $0.25 | — | $508.1M | — | — |
| Aug 3, 2023 | Q1 2023 | $0.25 | — | $527.7M | — | — |
| May 11, 2023 | Q4 2022 | $0.24 | — | $599.1M | — | — |
| Feb 7, 2023 | Q3 2022 | $0.13 | — | $474.8M | — | — |
| Nov 8, 2022 | Q2 2022 | $0.09 | — | $459.0M | — | — |
We use cookies for analytics. See our Privacy and Cookie Policy.